RaySearch Laboratories reports Q1 results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 17 2024
0mins
Should l Buy ?
Source: SeekingAlpha
- RaySearch Laboratories Press Release:
- Q1 earnings per share before/after dilution were SEK 1.07 (0.51).
- Net sales amounted to SEK 257.2 million.
- Order backlog stood at SEK 1,848.0 million compared to 1,903.3 million MSEK at the end of the period.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
